Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 32% ± 11% | |
endothelial cell | 4 studies | 21% ± 4% | |
glutamatergic neuron | 4 studies | 38% ± 11% | |
squamous epithelial cell | 3 studies | 32% ± 22% | |
ciliated cell | 3 studies | 24% ± 2% | |
GABAergic neuron | 3 studies | 29% ± 8% | |
basal cell | 3 studies | 24% ± 1% | |
astrocyte | 3 studies | 19% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 29% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 4966.07 | 459 / 459 | 100% | 96.30 | 1118 / 1118 |
esophagus | 100% | 7345.35 | 1445 / 1445 | 100% | 121.01 | 183 / 183 |
intestine | 100% | 4932.06 | 966 / 966 | 100% | 84.81 | 527 / 527 |
liver | 100% | 3415.58 | 226 / 226 | 100% | 47.02 | 406 / 406 |
prostate | 100% | 5190.84 | 245 / 245 | 100% | 82.01 | 502 / 502 |
stomach | 100% | 3896.40 | 359 / 359 | 100% | 84.89 | 286 / 286 |
uterus | 100% | 4455.19 | 170 / 170 | 100% | 86.74 | 459 / 459 |
lung | 100% | 5286.92 | 578 / 578 | 100% | 93.14 | 1154 / 1155 |
kidney | 100% | 4921.40 | 89 / 89 | 100% | 74.07 | 900 / 901 |
thymus | 100% | 6311.11 | 653 / 653 | 100% | 96.18 | 604 / 605 |
bladder | 100% | 5348.05 | 21 / 21 | 100% | 86.92 | 503 / 504 |
skin | 100% | 9139.16 | 1809 / 1809 | 100% | 83.37 | 471 / 472 |
ovary | 100% | 3890.46 | 180 / 180 | 100% | 74.84 | 429 / 430 |
pancreas | 100% | 2908.61 | 327 / 328 | 100% | 81.13 | 178 / 178 |
adrenal gland | 100% | 4952.58 | 258 / 258 | 97% | 45.30 | 223 / 230 |
brain | 94% | 2044.29 | 2475 / 2642 | 100% | 32.57 | 703 / 705 |
adipose | 100% | 5129.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 72.00 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 56.87 | 29 / 29 |
muscle | 100% | 4552.61 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4508.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 105.61 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 61.78 | 1 / 1 |
blood vessel | 100% | 4249.28 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3686.15 | 853 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 4031.78 | 895 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0062208 | Biological process | positive regulation of pattern recognition receptor signaling pathway |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_1905171 | Biological process | positive regulation of protein localization to phagocytic vesicle |
GO_0045087 | Biological process | innate immune response |
GO_0099072 | Biological process | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0018345 | Biological process | protein palmitoylation |
GO_0006869 | Biological process | lipid transport |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0098982 | Cellular component | GABA-ergic synapse |
GO_0000139 | Cellular component | Golgi membrane |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0099091 | Cellular component | postsynaptic specialization, intracellular component |
GO_0016409 | Molecular function | palmitoyltransferase activity |
GO_0019706 | Molecular function | protein-cysteine S-palmitoyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ZDHHC5 |
Protein name | protein S-acyltransferase (EC 2.3.1.225) Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375) Palmitoyltransferase (EC 2.3.1.225) |
Synonyms | KIAA1748 ZNF375 |
Description | FUNCTION: Palmitoyltransferase that catalyzes the addition of palmitate onto various protein substrates such as CTNND2, CD36, NOD1, NOD2, STAT3 and S1PR1 thus plays a role in various biological processes including cell adhesion, fatty acid uptake, bacterial sensing or cardiac functions . Plays an important role in the regulation of synapse efficacy by mediating palmitoylation of delta-catenin/CTNND2, thereby increasing synaptic delivery and surface stabilization of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs). Under basal conditions, remains at the synaptic membrane through FYN-mediated phosphorylation that prevents association with endocytic proteins . Neuronal activity enhances the internalization and trafficking of DHHC5 from spines to dendritic shafts where it palmitoylates delta-catenin/CTNND2 . Regulates cell adhesion at the plasma membrane by palmitoylating GOLGA7B and DSG2 . Plays a role in innate immune response by mediating the palmitoylation of NOD1 and NOD2 and their proper recruitment to the bacterial entry site and phagosomes . Participates also in fatty acid uptake by palmitoylating CD36 and thereby targeting it to the plasma membrane. Upon binding of fatty acids to CD36, gets phosphorylated by LYN leading to inactivation and subsequent CD36 caveolar endocytosis . Controls oligodendrocyte development by catalyzing STAT3 palmitoylation (By similarity). . |
Accessions | Q9C0B5 ENST00000529447.1 ENST00000527985.5 [Q9C0B5-2] ENST00000528177.5 ENST00000287169.8 [Q9C0B5-1] H0YEF4 ENST00000532842.1 E9PMA5 E9PJ97 |